Skip to content
Abierto

Vendor, Lawrence, MA, part of Revvity Inc.

Nexcelom Bioscience LLC

UEI ZZ22CHAA5732, CAGE 46UZ6

4 awards and -$18,734 obligated between February 26, 2025 and September 3, 2026, 0% under full and open competition, against 1.0 offers on average where reported.

Sells to

Awarding agencies by dollars.

Food and Drug Administration$0
National Institutes of Health-$18,734

Industries

NAICS on the awards, by dollars.

Analytical Laboratory Instrument ManufacturingNAICS 334516$0
Other Services (except Public Administration)NAICS 811219-$18,734

How it wins

Awards by competition, set-aside and type.

Competed Under SAP3
Not Competed1
Small Business Set Aside - Total1
Purchase Order4

Awards

Every award in the window, by dollars obligated.

ContractAwarding officeDescribed asObligated
HHSF223201410163APurchase Order, May 16, 2025, Competed Under SAP, 1 offersFDA Office of Acq Grant SVCSFood and Drug AdministrationImage Cytometer - the Purpose of This Modification Is to Cancel Non-Funded Items 3 & 4, Then Close Out the Contract.NAICS 334516, PSC 6640$0
75N93021P00501Purchase Order, August 27, 2026, Not Competed, 1 offersNational Institutes of Health NiaidNational Institutes of HealthTo Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 811219, PSC J065-$3,739
75N93021P00725Purchase Order, February 26, 2025, Competed Under SAP, 1 offersNational Institutes of Health NiaidNational Institutes of HealthNexcelom Bioscience (Ambis #2068257) Celigo Level a Service and Support Plan Pop 6/28/21-6/27/22NAICS 811219, PSC J066-$7,478
75N93021P00738Purchase Order, September 3, 2026, Competed Under SAP, 1 offersNational Institutes of Health NiaidNational Institutes of HealthTo Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 811219, PSC J066-$7,518
Places of performance
MassachusettsMaryland
Transactions
4 across 4 awards